- Filed
- Apr 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 4, 2025 | 5.09M sh |
| Cash And Equivalents | Q1 2025 · Feb 28, 2025 | $4.13K |
| Cash And Equivalents | Q1 2025 · Nov 30, 2024 | $1.86K |
| Current Liabilities | Q1 2025 · Feb 28, 2025 | $6.5M |
| Current Liabilities | Q1 2025 · Nov 30, 2024 | $6.63M |
| Total Liabilities | Q1 2025 · Feb 28, 2025 | $8.92M |
| Total Liabilities | Q1 2025 · Nov 30, 2024 | $9.15M |
| Current Assets | Q1 2025 · Feb 28, 2025 | $13M |
| Current Assets | Q1 2025 · Nov 30, 2024 | $13.12M |
| Total Assets | Q1 2025 · Feb 28, 2025 | $21M |
| Total Assets | Q1 2025 · Nov 30, 2024 | $21.24M |
| Long Term Debt | Q1 2025 · Nov 30, 2024 | $1.98M |
| Long Term Debt restated | Q1 2025 · Feb 29, 2024 | $1.98M |
| Shares Diluted | Q1 2025 · Feb 29, 2024 | 5.02M sh |
| Stock Repurchased | Q1 2025 · Feb 29, 2024 | $37.65K |
| Capex | Q1 2025 · Feb 29, 2024 | $281.17K |
| Operating Cash Flow | Q1 2025 · Feb 29, 2024 | −$99.27K |
| Short Term Debt restated | Q1 2025 · Feb 29, 2024 | $119.73K |
| Stockholders Equity | Q1 2025 · Feb 29, 2024 | $11.2M |
| Stockholders Equity | Q1 2025 · Nov 30, 2023 | $11.64M |
| Eps Diluted | Q1 2025 · Feb 29, 2024 | −$0.09 |
| Eps Basic | Q1 2025 · Feb 29, 2024 | −$0.09 |
| Sga Expense | Q1 2025 · Feb 29, 2024 | $1.23M |
| Net Income | Q1 2025 · Feb 29, 2024 | −$465.04K |
| Operating Income | Q1 2025 · Feb 29, 2024 | −$380.08K |
| Gross Profit | Q1 2025 · Feb 29, 2024 | $1.47M |
| Cost Of Revenue | Q1 2025 · Feb 29, 2024 | $4.25M |
| Revenue | Q1 2025 · Feb 29, 2024 | $5.72M |